White House, Allergan Spar Over 'Un-American' Claim
This article was originally published in Scrip
Executive Summary
The White House on April 6 fought back against accusations from Allergan PLC CEO Brent Saunders the Obama administration's move to institute new rules aimed at thwarting corporate inversion was "un-American" and had specifically been constructed to take down the company's $160bn merger deal with Pfizer Inc., which had, indeed, fallen apart in light of the US Treasury Department's actions.
You may also be interested in...
Allergan's Fishing For Deals, But Don't Expect A Big Catch
Allergan PLC will use its $36bn in after-tax cash and equity from the sale of its generics business to Teva Pharmaceutical Industries Ltd. to reduce debt, buy back shares of its stock, and to acquire companies or assets, but don't expect Allergan to catch any big fish in its dealmaking net.
Pfizer Split, Once Decided, Could Happen Quickly, CEO Says
Pfizer Inc. could complete a business breakup in about one year if the company decides to move forward with a split, CEO Ian Read said during the company’s first quarter sales and earnings call May 3.
Moderna's Valera Takes mRNA Approach To Combat Zika
With new funding in hand, Moderna and its infectious disease venture Valera are going full-speed ahead with a Zika vaccine, taking an mRNA approach, which they said could be a more rapid strategy to try to stop the disease.